Trending:
Nation's evolving role in global pharma enhanced

Samsung Epis Holdings has opened its first biopharmaceutical research and development center in China focused on antibody-drug conjugates, or ADCs, joining a growing list of multinational drugmakers deepening their presence in a country that has become one of the world's most active hubs for cancer...

El Tiempo
El Tiempo

www.eltiempo.com




See also: